The global adaptogenic mushrooms market demand was USD 11.72 billion in 2022, and expanding at a CAGR of 10.8% during the forecast period. The market growth is driven by the increasing interest among consumers towards natural health remedies coupled with rising awareness towards the benefits of mushrooms. Furthermore, the rising stress levels among consumers are a major factor fuelling the demand for the market. The COVID-19 pandemic positively impacted the demand for adaptogenic mushrooms owing to the rise in consumers opting for immunity-rich foods. The pandemic also highlighted the demand for functional benefits derived from mushrooms thereby fueling the demand.
Adaptogenic mushrooms have gained popularity in the recent years due to their potential health benefits and the body’s ability to adapt to stress. As people become more aware of the potential side effects of pharmaceutical drugs, they are turning to natural remedies for health concerns. Adaptogenic mushrooms are a natural and safe way to support the body's immune system and reduce stress levels.
Consumers are increasingly interested in foods that offer health benefits. Adaptogenic mushrooms are considered a functional food, providing health benefits beyond basic nutrition. Adaptogenic mushrooms can be easily added to smoothies, teas, and other foods to provide a range of health benefits. As more people become interested in functional foods, the demand for adaptogenic mushrooms is likely to grow.
Furthermore, the rise in the number of companies offering innovative products using adaptogenic mushrooms is also supporting the growth of the market. In March 2023, a U.S. based privately owned coffee shop vida e caffè partnered with GOODMIND, a provider of functional mushrooms to launch functional mushroom cappuccino and functional mushroom sachet. The functional mushroom sachets include mushrooms such as chaga, shiitake, cordyceps, and Lion’s mane.
Reishi segment dominated the product segment accounting for the highest revenue share of 23.09% in 2021. The demand for reishi as an adaptogenic mushroom is being driven by its potential health benefits and traditional use in herbal medicine. Reishi mushrooms have been used in traditional Chinese medicine to promote longevity and support immune system function.Moreover, adaptogenic mushrooms like reishi are gaining popularity in the wellness industry as a natural way to support the body's ability to adapt to stress and promote overall well-being. As consumers become more interested in natural remedies and alternative medicine, the demand for reishi is likely to continue to grow. For instance, a U.S. headquartered mushroom supplements-based company VidaCap announced the launch of melatonin sleep capsules extracted from reishi powder and passion flower.
The cordyceps segment is predicted to expand at a CAGR of 11.1% during the forecast period. Public’s increasing interest in natural health products can be attributed to several factors, such as concerns about the potential side effects of pharmaceutical drugs, desire for more holistic approaches to healthcare, and the availability of information on the benefits of natural remedies through the internet and social media. As consumers become more health-conscious, they are more likely to seek out natural products like cordyceps that has health benefits.
The stress & anxiety relief segment dominated the application segment with the largest share of 32.09 % in 2021. The perceived health benefits derived from adaptogenic mushrooms such as regulation of adrenal glands, improving oxygen uptake, boosting energy levels, and reducing inflammation are the major driving the demand for the segment. In addition, the rise in cases of chronic inflammation are also supporting the usage of adaptogenic mushrooms for anxiety and stress. As per the Global Burden of Disease, close to 50% of all deaths globally are caused by chronic inflammation and other chronic diseases.
The immunity booster segment is anticipated to expand at a CAGR of 10.9% during the forecast period. Adaptogenic mushrooms have gained popularity as a functional food and supplement due to their rich content of biologically active compounds, such as beta-glucans, polysaccharides, triterpenoids, and ergosterol. These compounds have been shown to have immunomodulatory, anti-inflammatory, and antioxidant effects, among other potential health benefits. In recent years, there has been a significant increase in demand for functional foods and supplements, driven by growing consumer interest in preventative health and wellness. Consumers are increasingly looking for products that can help support their health and prevent disease thereby fueling the demand for immunity rich adaptogenic mushrooms.
The dried segment dominated the form segment with the largest share of 57.1% in 2021. Factors such as longer shelf life, concentrated flavor, and nutrient density offered by dried mushrooms make them an ideal ingredient for food and beverage manufacturers. Drying the mushrooms helps in increasing their nutrient density by removing water weight and concentrating nutrients like vitamins, minerals, and antioxidants. Several medicinal mushrooms consumed in dried form have stronger adaptogenic properties when dried. The drying process may help to break down the tough cell walls of the mushrooms, making their beneficial compounds more accessible to the body.
The fresh/whole segment is anticipated to expand at the fastest CAGR of 11.1% during the forecast period. Growing consumer awareness towards sustainably sourced ingredients coupled with high demand for nutritional foods is boosting the demand for fresh mushrooms. Fresh mushrooms have a more delicate and nuanced flavor than dried mushrooms, which can be more concentrated and earthy.
Asia Pacific led the market and accounted for 41.3% share of the global revenue in 2022. The demand for adaptogenic mushrooms in the Asia Pacific has been steadily increasing in the recent years. Adaptogenic mushrooms are a type of medicinal mushroom that has been used for centuries in traditional medicines in Asia and has a range of health benefits, including stress relief, immune system support, and anti-inflammatory effects. Countries such as China, Japan, and Korea have a long history of using adaptogenic mushrooms in their traditional medicine practices, and as such, these countries have been at the forefront of the adaptogenic mushrooms market in the Asia Pacific.
The North American adaptogenic mushrooms market is estimated to expand at a CAGR of 11.1% from 2022-2030. The perceived health benefits offered by adaptogenic mushrooms coupled with rising awareness among consumers about overall well-being and health is supporting the growth of the region. Several companies operating in the region are launching adaptogenic beverages to cater to the growing demand for better-for-you beverages. For instance, an U.S. based provider of beverage mixes has introduced Classic and Café Rasa, two adaptogenic and mushroom beverage mixes that serve as coffee alternatives. Classic Rasa features six adaptogens and offers a robust, roasty, and rich taste.
The market is anticipated to witness competition among the companies due to the presence of many players across the industry. Several companies are increasing their product portfolio to gain a competitive edge in the market.Manufacturers are engaged in research & development activities related to products that are used in the manufacturing of adaptogenic mushrooms. In July 2022, Four Sigmatic announced the launch of ground coffee sourced from adaptogenic mushrooms. The key companies operating in the global adaptogenic mushrooms market are as follows.
Four Sigmatic
Om Mushroom Superfood
Real Mushrooms
Sun Potion
Mushroom Science
Paul E. Stamets and Fungi Perfecti, LLC,
Terrasoul Superfoods
Nammex
Report Attribute |
Details |
Market size value in 2023 |
USD 12.79 billion |
Revenue forecast in 2030 |
USD 26.62 billion |
Growth Rate (Revenue) |
CAGR of 10.8% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2017 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD Million, and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, form, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea, Australia & New Zealand, Brazil, Argentina; South Africa; UAE |
Key companies profiled |
Four Sigmatic; Om Mushroom Superfood; Real Mushrooms; Sun Potion; Mushroom Science; Paul E. Stamets and Fungi Perfecti, LLC,; Terrasoul Superfoods; Nammex |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global adaptogenic mushrooms market report based on product, application, form, and region:
Product Outlook (Revenue, USD Million; 2017 - 2030)
Reishi
Chaga
Turkey Tail
Lion’s Mane
Cordyceps
Others
Application Outlook (Revenue, USD Million, 2017 - 2030)
Immunity Booster
Stress & Anxiety Relief
Cognitive , Brain Support & Mental Health Support
Insomnia Treatment
Others
Form Outlook (Revenue, USD Million, 2017 - 2030)
Fresh/Whole
Dried
Processed
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia & New Zealand
Central & South America
Brazil
Argentina
Middle East & Africa
South Africa
UAE
b. The global adaptogenic mushrooms market is expected to grow at a compound annual growth rate of 10.8% from 2023 to 2030 to reach USD 26.62 billion by 2030.
b. The global adaptogenic mushrooms market size was estimated at USD 11.72 billion in 2022 and is expected to reach USD 12.79 billion in 2023.
b. Asia Pacific region dominated the adaptogenic mushrooms market with a revenue share of 41.3% in the year 2022 owing to the high demand and large consumer base present in the countries like China and India.
b. Some of the key market players in the adaptogenic mushrooms market are Four Sigmatic, Om Mushroom Superfood, Real Mushrooms, Sun Potion, Mushroom Science, Paul E. Stamets and Fungi Perfecti, LLC, Terrasoul Superfoods, and Nammex.
b. Key factors that are driving the adaptogenic mushrooms market growth is increasing consumer awareness regarding wellness & health, and increasing investments in the wellness industry
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."